z-logo
open-access-imgOpen Access
Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
Author(s) -
Antonin Lévy,
C. FaivreFinn
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.04.45
Subject(s) - radiation therapy , stage (stratigraphy) , lung cancer , medicine , oncology , cancer , biology , paleontology
Department of Radiation Oncology, Institut d’Oncologie Thoracique (IOT), Gustave Roussy, Villejuif, France; Univ Paris Sud, Université ParisSaclay, Le Kremlin-Bicêtre, France; INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK Correspondence to: Antonin Levy, MD, PhD. Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France. Email: Antonin.LEVY@gustaveroussy.fr. Provenance and Peer Review: This article was commissioned and reviewed by the Section Editor Dr. Chun-Ru Chien (Director, Department of Radiation Oncology, China Medical University Hsinchu Hospital, Hsinchu; Professor, Department of Radiation Oncology, China Medical University, Taichung). Comment on: Hu X, Bao Y, Xu Y, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer 2020;126:840-9.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom